{"id":"W2142739119","doi":"10.1093/jnci/dji250","title":"Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17","year":2005,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1120,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Letrozole; Medicine; Hazard ratio; Breast cancer; Tamoxifen; Internal medicine; Interim analysis; Adjuvant therapy; Oncology; Aromatase inhibitor; Placebo; Clinical endpoint; Proportional hazards model; Surgery; Gynecology; Cancer; Randomized controlled trial; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005130966,0.0002220452,0.0005853784,0.0001133013,0.0001117627,0.00001978175,0.0003632733,0.0001197984,0.0001133299],"category_scores_gemma":[0.0001734422,0.0001517518,0.0004818279,0.0002128613,0.0001757425,0.00004933887,0.00007912391,0.0002079945,0.000001722091],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005043226,"about_ca_system_score_gemma":0.0008954337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001161314,"about_ca_topic_score_gemma":0.0007202562,"domain_scores_codex":[0.9980744,0.0001665401,0.0006702559,0.0002295797,0.0006603107,0.0001989694],"domain_scores_gemma":[0.9986629,0.00007446288,0.0006139011,0.0001253144,0.0004661104,0.0000572366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8623465,0.0006016916,0.005086747,0.000007677231,0.003702861,0.000008230109,0.0007706118,0.004989962,0.1004496,0.0001173343,0.01072993,0.01118885],"study_design_scores_gemma":[0.7994563,0.000232758,0.04208099,0.000384775,0.0003013389,0.00004525794,0.00006079426,0.00004839862,0.1433133,0.0004758319,0.01323851,0.0003617375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883151,0.003756118,0.0000217493,0.004821301,0.001807561,0.0004538116,0.000507907,0.000003791898,0.0003126355],"genre_scores_gemma":[0.9946377,0.002231903,0.0002207615,0.0008845631,0.0016773,0.00008211312,0.00005841679,0.00001797878,0.0001892679],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06289017,"threshold_uncertainty_score":0.6188259,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01683296835497545,"score_gpt":0.3131470373556251,"score_spread":0.2963140690006497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}